UMB 425 is being called a breakthrough in the development of therapeutics to treat chronic pain, acts on two different opioid receptors with diminished tolerance over time and no obvious toxic effects.
A team of researchers led by Andrew Coop, PhD, professor and chair of the Department of Pharmaceutical Sciences (PSC) at the University of Maryland School of Pharmacy (UMSOP), has developed a new opioid drug that shows great potential to advance treatment and improve quality of life for individuals living with chronic pain. Spotlighted in a recent issue of ACS Chemical Neuroscience, the compound, known as UMB 425, is as strong as morphine, but displays diminished tolerance over time with no obvious toxic effects.
“UMB 425 is a breakthrough in the development of therapeutics to treat chronic pain,” says Coop. “Unlike other drugs developed to act on only one biological target, UMB 425 acts on two different opioid receptors in the body. When activated at the same time, these receptors work together to provide pain relief and slow the body’s development of tolerance to the drug. This diminished tolerance allows a lower dose of the opioid to be administered for a longer time period, while still achieving the same level of pain relief.”
For individuals living with chronic pain, either as a result of injury or disease such as arthritis, opioids are the standard treatment. But as the dosage increases to offset the body’s tolerance to their effects, opioids cause a number of adverse effects, including constipation, nausea, drowsiness, and dizziness. The unique dual-profile of UMB 425 – made possible through Coop’s collaborations with Alexander MacKerell, PhD, professor in PSC and director of the School’s Computer Aided Drug Design Center, and Maureen Kane, PhD, assistant professor in PSC and co-director of the School’s Mass Spectrometry Facility – provides both pain relief as well as diminished tolerance in one drug.
“Historically, medicinal chemists have developed drugs aimed at only one biological target,” says Coop. “However, two drugs administered together have the potential to metabolize differently in different individuals, as well as affect patients’ adherence to both drugs. A single compound that is able to provide both pain relief and diminished tolerance has the advantage of a defined ratio that we can optimize to ensure patients receive the maximum pain relief, while experiencing minimum adverse effects.”
Coop and his team conducted several in vitro and in vivo studies to determine the drug’s effectiveness in alleviating pain and diminishing tolerance over time. If future research and clinical trials are successful, UMB 425 could have a significant impact on the treatment and quality of life for individuals living with chronic pain.
“The clinical implication of this research has the potential to be tremendous,” says Mary Lynn McPherson, PharmD, BCPS, CPE, professor and vice chair for academic affairs in the Department of Pharmacy Practice and Science, and an international authority in the fields of pain management and palliative care. “If clinicians can prescribe lower doses of opioids, they will not have to raise a patient’s dose because of tolerance to the analgesic effects. Using lower doses will result in less severe adverse effects for the patient, both short-term effects such as nausea and constipation, as well as long-term adverse effects on the endocrine and immunologic systems. This would be a highly significant advance in pain management.”
The Latest Bing News on:
- Chronic pain: Medical cannabis has huge potential to help suffererson September 19, 2021 at 12:30 am
I had two knee reconstructions during my Olympic career that left me living with chronic pain and often unable to get out of bed. Throughout my life I have also suffered from endometriosis and I ...
- I am a young person living with chronic pain. Please don’t tell me it’s just part of God’s plan.on September 17, 2021 at 12:49 pm
I live with chronic pain, and often it seems like no one really understands what this means. Having chronic pain, especially as a young person, can often feel lonely and isolating.
- Medium-Weight Mesh Fails to Reduce Chronic Pain and Other Complications of Ventral Hernia Repairon September 16, 2021 at 2:37 pm
Medium-weight mesh was introduced to cut chronic pain associated with heavy-weight mesh, but it hasn't been subject to a randomized trial until now.
- Present Tense: Being Present Doesn’t Have To Hurt, Even with Chronic Painon September 16, 2021 at 12:33 pm
Share on Pinterest Illustration by Brittany England HL-1462518-Present_Tense-Relaxation_Is_a_Skill_Not_a_Luxury Illustration by Brittany England If you live life with chronic pain, you’ve ...
- Neuros Medical Announces Completion of Enrollment in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Painon September 15, 2021 at 8:24 am
CLEVELAND and ALISO VIEJO, Calif., Sept. 15, 2021 /PRNewswire/ -- Neuros Medical, Inc., a medical device company developing innovative ...
- The promise of regenerative medicine to treat chronic painon September 15, 2021 at 7:48 am
The use of regenerative medicine to lessen chronic pain holds enormous potential, and the body of evidence to support the practice is growing, said Alexios Carayannopoulos, DO, MPH, DABPMR, chief of ...
- Man planks for over 9 hours with chronic pain to break Guinness World recordon September 15, 2021 at 6:20 am
Daniel Scali, of Australia, broke the Guinness World record for longest plank hold at over 9 hours while suffering from chronic pain.
- 28-year-old man with chronic pain sets world record by holding plank for over 9 hourson September 14, 2021 at 5:13 am
When Daniel Scali broke the record last month, the tough feat was made even more difficult by complex regional pain syndrome, or CRPS, which causes almost constant pain in his left arm.
- Best Tools For Managing Chronic Painon September 13, 2021 at 6:08 am
Our editors independently produce original content based on thorough research and guidance from the Forbes Health Advisory Board. Commissions we may earn from partner links on this page do not ...
- Medical cannabis unlikely to benefit most chronic pain patients, international researchers sayon September 10, 2021 at 11:47 am
Medical cannabis might be a helpful therapy for some people who have chronic pain, but it’s unlikely to benefit most, new guidelines say.
The Latest Google Headlines on:
The Latest Bing News on:
- North Shore Airport, Umnak Island, United States [ UMB / ]on August 17, 2021 at 5:00 pm
Looking for information on North Shore Airport, Umnak Island, United States? Know about North Shore Airport in detail. Find out the location of North Shore Airport on United States map and also find ...
- Carlyle (CG) Stock up 6.6% on Q2 Earnings Beat, Expenses Riseon July 30, 2021 at 7:12 am
Fee revenues in the second quarter increased 5.1% year over year to $425.4 million. A rise in fund management fees ... You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
- Trains Between Hapa and Ambala Cantonment • List of Hapa - Ambala Cantonment Trainson May 12, 2018 at 11:57 am
Find all trains running between Ambala Cantonment (UMB) and Hapa (HAPA). This page gives train name, train number and timing of trains operating on the Ambala Cantonment - Hapa route. There are 4 ...